General Information of Drug (ID: DM0P729)

Drug Name
GSK461364 Drug Info
Synonyms
GSK461364; 929095-18-1; GSK-461364; 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1h-benzimidazol-1-yl]-3-[(1r)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide; GSK 461364; UNII-8QO27TK6Q4; GSK-461364A; (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide; 8QO27TK6Q4; CHEMBL1908394; GSK461364A; ZHJGWYRLJUCMRT-QGZVFWFLSA-N; SCHEMBL310080; GTPL5684; C27H28F3N5O2S; CTK8B7590; CHEBI:91333; DTXSID60239197; MolPort-016-633-304; BCP01720; GSK 461364A
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
15983966
ChEBI ID
CHEMBL1908394
CAS Number
CAS 929095-18-1
TTD ID
D08RMJ

Molecule-level Activity Landscape of This Drug

Molecule Name Gene Name UniProt ID Type IC50 (nM) Details
Loading IC50 data...
Molecule Name Gene Name UniProt ID Type Kd (nM) Details
Loading Kd data...
Molecule Name Gene Name UniProt ID Type Ki (nM) Details
Loading Ki data...

Experimental Drug Sensitivity Data Across Cancer Cell Lines

Cell Line Related Disease IC50 (Log₂ µM) Original Dataset Details
Loading Cell Activity data...

Cytotoxic Activity Landscape of This Drug

Loading...
Cell Line Disease Value (nM) ChEMBL Assay ID Details
Loading ChEMBL activity data...